In our study we investigated a homogeneous cohort of 38 patients with ED-SCLC, assessing the role of three key genes encoding crucial factors of the NER pathway, ERCC1, ERCC2, and ERCC5. This evidence concerns the gene ERCC2 and small cell lung carcinoma.